Albumin solution ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 20 | Adrenoleukodystrophy | 1 |
20. Adrenoleukodystrophy
Clinical trials : 53 / Drugs : 88 - (DrugBank : 31) / Drug target genes : 23 - Drug target pathways : 123
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04303416 (ClinicalTrials.gov) | March 9, 2020 | 6/3/2020 | Plasma Exchange With Albumin in AMN Patients | Effect of Plasma Exchange With Albumin in Patients With Adrenomyeloneuropathy: Unicentric, Single Arm, Proof of Concept Study. | Adrenomyeloneuropathy;Adrenoleukodystrophy | Drug: Albumin solution | Onofre, Aurora Pujol, M.D. | NULL | Active, not recruiting | 18 Years | 65 Years | Male | 5 | Phase 2/Phase 3 | Spain |